Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barreiro

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Inflammatory Bowel Diseases|August 10, 2011
Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter studyM Barreiro-de Acosta, O García-Bosch, R Souto, et al.
Human Immunology|October 15, 2013
Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximabL M Medrano, C Taxonera, A Márquez, et al.
Alimentary Pharmacology & Therapeutics|December 8, 2010
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximabC Taxonera, J Estellés, I Fernández-Blanco, et al.
Alimentary Pharmacology & Therapeutics|December 7, 2011
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre studyM Chaparro, P Burgueño, E Iglesias, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 10, 2021
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE studyG Bastida, I Marín-Jiménez, A Forés, et al.
Biochemical Pharmacology|September 25, 2016
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximabB Hernández-Breijo, M Chaparro, D Cano-Martínez, et al.
Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.
Digestive Diseases and Sciences|July 6, 2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel diseaseF Argüelles-Arias, L Castro-Laria, T Lobatón, et al.
Journal of Crohn'S & Colitis|January 24, 2016
Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of RetreatmentD Carpio, A Jauregui-Amezaga, R de Francisco, et al.
Radiologia|June 2, 2023
Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus documentM Barreiro-Pérez, B Cabeza, D Calvo, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Inflammatory Bowel Diseases|August 10, 2011
Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter studyM Barreiro-de Acosta, O García-Bosch, R Souto, et al.
Human Immunology|October 15, 2013
Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximabL M Medrano, C Taxonera, A Márquez, et al.
Alimentary Pharmacology & Therapeutics|December 8, 2010
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximabC Taxonera, J Estellés, I Fernández-Blanco, et al.
Alimentary Pharmacology & Therapeutics|December 7, 2011
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre studyM Chaparro, P Burgueño, E Iglesias, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 10, 2021
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE studyG Bastida, I Marín-Jiménez, A Forés, et al.
Biochemical Pharmacology|September 25, 2016
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximabB Hernández-Breijo, M Chaparro, D Cano-Martínez, et al.
Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.
Digestive Diseases and Sciences|July 6, 2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel diseaseF Argüelles-Arias, L Castro-Laria, T Lobatón, et al.
Journal of Crohn'S & Colitis|January 24, 2016
Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of RetreatmentD Carpio, A Jauregui-Amezaga, R de Francisco, et al.
Radiologia|June 2, 2023
Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus documentM Barreiro-Pérez, B Cabeza, D Calvo, et al.
Pageof 8